ABOUT US
A global leader in innovative genomic
technology and diagnostic tests.

What’s new at Agendia?
Get the latest updates on our company and products, as well as new developments in genomic science.
News
In the News
News
Media Releases
FOCUS Study Shows MammaPrint Accurately Identifies Extremely Indolent Cancers
Findings confirm subanalysis of STO-3 trial and provide foundation for consideration of de-escalation of treatment in post-menopausal patients guided by genomic testing IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ December 9, 2020 โ Agendia, Inc., Read More
Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer
Co-development program will utilize next-generation digital pathology platform and AI-based technology to provide real-time genomic testing results Partnership to create new products enabling faster access to predictive information in treatment planning for patients with breast Read More
Agendia to Showcase Robust Clinical Research at SABCS 2020 Emphasizing Need for Diversity of Data to Treat Breast Cancer Patients
Variety of data confirm the importance of applying genomic analysis to explore and improve outcomes for subpopulations of breast cancer patients IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ NOVEMBER 17, 2020 โ Agendia, Inc., a Read More
Agendia to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Agendia, Inc., a world leader in precision oncology for breast cancer, today announced its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference, which takes place November 30 โ December 3, 2020. Read More